Abstract:Objective: Huamaoyan Granules (HMYG) and Huamaoyan Capsules (HMYC) are Chinese patent medicines with different dosage forms of the same prescription. Due to the different preparation process, the chemical composition of these Chinese patent medicines varies greatly among different forms, but there were few studies on the difference comparison and quality control of them. In order to improve the effectiveness and safety in its clinical application, an idea combining high performance liquid chromatography (HPLC) and chemometrics was put forward to study the quality control of Chinese patent medicines in different dosage forms of the same prescription. Methods: The differential markers of HMYG and HMYC were explored based on HPLC fingerprint and chemometrics including orthogonal projections to latent structures-discriminant analysis (OPLS-DA), principal component analysis (PCA), and hierarchical cluster analysis (HCA). Finally, the quantitative analysis method of related components was established by HPLC. Results: A quality control method for HMYG and HMYC was established. Firstly, the chemical components of HMYG and HMYC were systematically analyzed by HPLC fingerprinting. Further exploration showed that there were 20 characteristic peaks and 57 common peaks. Then, the potential differential markers between HMYG and HMYC were explored by chemometrics, and the differential markers were screened after intersection with the 20 characteristic peaks. Finally, HPLC quantitative analysis methods for nine components were established, including seven differential markers (neochlorogenic acid, protocatechualdehyde, chlorogenic acid, cryptochlorogenic acid, caffeic acid, rosmarinic acid and salvianolic acid A). The results of HPLC quantitative analysis showed that the contents of eight components in HMYG and HMYC samples were significantly different. According to the above results, the differential markers between HMYG and HMYC screened based on HPLC fingerprint and chemometrics can effectively characterize the differences between the two dosage forms. Conclusion: The present work provides a rapid and effective method for routine quality evaluation and control of HMYG and HMYC. This work also provides feasible methods for the quality evaluation and control of Chinese patent medicines with different dosage forms of the same prescription.

[Research strategy for homogenization feeding of Chinese patent medicines]

Feedforward Control Strategy and Its Application in Quality Improvement of Ethanol Precipitation Process of Danhong Injection

An Approach to Optimize the Batch Mixing Process for Improving the Quality Consistency of the Products Made from Traditional Chinese Medicines

[Lean strategy for data mining and continuous improvement of Chinese pharmaceutical process: a case study of sporoderm-removal Ganoderma lucidum spore powder].

Research progress on feedforward control strategy and its application prospect in quality control of Chinese materia medica

Optimization of membrane dispersion ethanol precipitation process with a set of temperature control improved equipment.

[Overview and prospects of traditional Chinese medicine blending technology oriented by quality consistency]

[Research on evaluation criteria over quality as core index of high grade Chinese patent medicine]

[Quality standards of medicinal and food homologous substances based on dual attributes]

Quality by design for herbal drugs: a feedforward control strategy and an approach to define the acceptable ranges of critical quality attributes.

Discriminatory Components Retracing Strategy For Monitoring The Preparation Procedure Of Chinese Patent Medicines By Fingerprint And Chemometric Analysis

Batch-to-Batch Quality Consistency Evaluation of Botanical Drug Products Using Multivariate Statistical Analysis of the Chromatographic Fingerprint

[Application prospect of new technology and new equipment in production of Chinese patent medicine]

HPLC combined with chemometrics for quality control of Huamoyan Granules or Capsules

An Integrated Strategy for Holistic Quality Identification of Chinese Patent Medicine: Liuwei Dihuang Pills As a Case Study

Optimization of the extraction process for Shenshou Taiyi powder based on Box-Behnken experimental design, standard relation, and FAHP-CRITIC methods

[Particle design for improving taste and homogeneity of traditional Chinese medicinal powder: taking Zhuhuang Chuihou Powder as an example]

[Evaluation for druggability of traditional Chinese medicine preparations in medical institutions based on human use experience]

A Unique Issue in the Standardization of Chinese Materia Medica: Processing

[Research on feedforward control method of mixing process for compound Danshen Dripping Pills based on quality by design(QbD)].

Study Design and Implementation for Population Pharmacokinetics of Chinese Medicine: an Expert Consensus